Skip to main content

Security report for octapharma.com

Octapharma AG · Healthcare · Switzerland

High risk. 7 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

49/100

Risk levelHigh

0–100, higher is better. How it is calculated

Octapharma AG is a leading global manufacturer of human protein therapies derived from plasma and human cell lines, serving patients in over 120 countries. The company operates a large network of plasma donation centers and production facilities, emphasizing patient engagement and innovation in immunotherapy, haematology, and critical care. The website is professionally designed with comprehensive content, including employee stories, press releases, and detailed product information. Technically, the site uses modern frameworks like Next.js and is hosted on AWS infrastructure, but suffers from critical SSL/TLS configuration issues, lacking a valid certificate and modern protocol support. Security headers are partially implemented, but the absence of HTTPS severely impacts the security posture. Privacy compliance is well addressed with clear policies and a cookie consent mechanism. Overall, the site demonstrates strong business credibility and content quality but requires urgent security improvements to protect user data and trust.

Scanned

NIS2 and GDPR posture

GDPR outside view
0/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

Need hands-on remediation? Email guard@offseq.com

Keep watching octapharma.com

This scan found 16 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
60
Email security
50
DNS health
85
Network security
100
GDPR outside view
0
Average
49

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Octapharma holds a strong market position as a privately owned enterprise in the healthcare sector, specializing in plasma-derived medicinal products. Their business model integrates plasma collection, manufacturing, R&D, and global distribution. The company targets patients, healthcare professionals, and potential employees, leveraging a family-owned culture and emphasizing sustainability and innovation. Their global footprint and extensive product portfolio provide competitive advantages. Partnerships with plasma centers and healthcare organizations enhance their ecosystem. Growth indicators include recent press releases on clinical trials and NHS collaborations. The website reflects a mature digital presence supporting their business objectives.

Security posture

The current security maturity level is low due to the absence of a valid SSL certificate and lack of TLS protocol support, exposing users to potential interception and data integrity risks. While some security headers are present, critical best practices like HSTS enforcement and OCSP stapling are missing. No visible incident response or vulnerability disclosure policies reduce transparency and preparedness. The cookie consent mechanism and privacy policies indicate awareness of compliance requirements, but the technical security gaps pose significant business risks. Immediate remediation of SSL/TLS and enhancement of security controls are necessary to improve the security posture.

Recommendations

  1. Obtain and deploy a valid SSL/TLS certificate supporting TLS 1.2 and TLS 1.3 protocols.
  2. Enable and enforce HTTP Strict Transport Security (HSTS) with includeSubDomains and preload options.
  3. Implement OCSP stapling and session resumption to improve SSL performance and security.
  4. Publish a clear incident response and vulnerability disclosure policy to enhance transparency.
  5. Regularly audit and update security headers and configurations to align with best practices.
Technical notes

Notes

The website is built on a modern React-based framework (Next.js) and uses Storyblok as a CMS, hosted likely on AWS infrastructure. The site is mobile-optimized with good accessibility and SEO practices. However, performance metrics are missing or zero, indicating potential issues with load time measurement or optimization. The absence of HTTPS and TLS support is a critical technical flaw. The site uses Usercentrics for cookie consent and Google Analytics and Matomo for analytics, reflecting a mature digital marketing setup. Technical debt is low in terms of technology stack but high in security implementation. Modernization efforts should prioritize security enhancements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 49/100High25 findingsView report
Reviews of this site

Share your experience with octapharma.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review octapharma.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.